Search research articles
Contact Us
Filters
Showing results (291-300 of 300) with videos related to
Page
of 30
Sort By:
You have reached the last page of results.
This site can display upto 300 results.
International Journal of Cancer
|
April 20, 2018
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
Henning Reis, Kristan E van der Vos, Christian Niedworok, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 12, 2023
Early Detection of Lung Cancer Using Small RNAs
Tobias Sikosek, Rastislav Horos, Franziska Trudzinski, et al.
Journal of Hematology & Oncology
|
July 10, 2026
Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors
Ignacio Melero, María de Miguel, Elena Garralda Cabanas, et al.
Lancet (London, England)
|
April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
European Journal of Epidemiology
|
April 5, 2023
Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication Platform
Daniel Maier, Jörg Janne Vehreschild, Barbara Uhl, et al.
Nature
|
March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapy
Julie George, Lukas Maas, Nima Abedpour, et al.
Nature
|
February 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature Medicine
|
January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Juanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Nature
|
December 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature
|
July 14, 2015
Comprehensive genomic profiles of small cell lung cancer
Julie George, Jing Shan Lim, Se Jin Jang, et al.
Page
of 30
Search research articles
Search
Showing results (291-300 of 300) with videos related to
Sort By:
Page
of 30
You have reached the last page of results.
This site can display upto 300 results.
International Journal of Cancer
|
April 20, 2018
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
Henning Reis, Kristan E van der Vos, Christian Niedworok, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 12, 2023
Early Detection of Lung Cancer Using Small RNAs
Tobias Sikosek, Rastislav Horos, Franziska Trudzinski, et al.
Journal of Hematology & Oncology
|
July 10, 2026
Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors
Ignacio Melero, María de Miguel, Elena Garralda Cabanas, et al.
Lancet (London, England)
|
April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
European Journal of Epidemiology
|
April 5, 2023
Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication Platform
Daniel Maier, Jörg Janne Vehreschild, Barbara Uhl, et al.
Nature
|
March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapy
Julie George, Lukas Maas, Nima Abedpour, et al.
Nature
|
February 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature Medicine
|
January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Juanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Nature
|
December 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature
|
July 14, 2015
Comprehensive genomic profiles of small cell lung cancer
Julie George, Jing Shan Lim, Se Jin Jang, et al.
Page
of 30